Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report
The Oncologist · 05.02.2026 · 31 (3)
DOI: 10.1093/oncolo/oyaf421 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Oncologist, online erschienen am 19.12.2025. Verfasst von Vitor Jodar Cavalheiro und 9 weiteren Autor:innen. Beteiligte Einrichtung: ICESP-Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma, Adenomatous Polyposis Coli Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Mutations in the adenomatous polyposis coli (APC) gene are frequent in colorectal cancer (CRC), whereas epidermal growth factor receptor (EGFR) mutations, particularly the L858R variant, are exceedingly rare. Their coexistence in CRC is rare and poorly described in the literature and poses diagnostic and therapeutic challenges. We describe a 69-year-old man with a history of resected CRC who presented with a lung mass and adrenal lesions, initially suspected as metastatic non-small cell lung cancer (NSCLC). Biopsy revealed poorly differentiated carcinoma with immunohistochemistry suggestive of gastrointestinal origin. Due to doubts regarding the primary site, it was decided to start systemic treatment with mFOLFIRINOX while awaiting NGS. After 7 cycles, a partial radiologic and clinical response was observed. Next-generation sequencing (NGS) became available and identified an EGFR L858R mutation, favoring NSCLC. Chemotherapy was paused, and the patient was treated with gefitinib. Rapid disease progression ensued, with new brain metastases. Expanded NGS subsequently revealed concurrent APC and TP53 pathogenic variants, confirming the diagnosis of metastatic CRC harboring co-occurring EGFR and APC mutations. The patient died 10 months after diagnosis. This case underscores the critical role of comprehensive molecular profiling via NGS in accurately diagnosing complex oncologic presentations. To our knowledge, this is the first case report of APC and EGFR L858R co-mutation in colorectal cancer. For this patient, the misclassification delayed the use of more appropriate therapies for CRC, which may have impacted clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICESP-Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.
ORCID-Profile: Vitor Jodar Cavalheiro, Daniel Santos Rocha Sobral Filho, Gilberto de Castro Junior, Jorge Sabbaga, Milena Perez Mak, Paulo Marcelo Gehm Hoff
Zitieren
APA
Cavalheiro, V. J., Sobral Filho, D. S. R., de Oliveira, G. M., da Fonseca, M. D. R. N., Travessini, G., Soares, I. C., de Castro Junior, G., Sabbaga, J., Mak, M. P., & Gehm Hoff, P. M. (2026). Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report. The Oncologist, 31(3). https://doi.org/10.1093/oncolo/oyaf421
Vancouver
Cavalheiro VJ, Sobral Filho DSR, de Oliveira GM, da Fonseca MDRN, Travessini G, Soares IC, et al. Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report. The Oncologist. 2026;31(3). doi:10.1093/oncolo/oyaf421
BibTeX
@article{Cavalheiro2026,
author = {Cavalheiro, Vitor Jodar and Sobral Filho, Daniel Santos Rocha and de Oliveira, Giulia Mazaro and da Fonseca, Manuela Del Rio Navarrete and Travessini, Gabriel and Soares, Ibere Cauduro and de Castro Junior, Gilberto and Sabbaga, Jorge and Mak, Milena Perez and Gehm Hoff, Paulo Marcelo},
title = {Metastatic colorectal adenocarcinoma with APC and EGFR L858R co-mutations: a case report},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {3},
doi = {10.1093/oncolo/oyaf421}
}
EUVIMED